
In a study of 351 women with BI-RADS 3-5 non-mass enhancement breast lesions, researchers found that multiparametric MRI offered 98.4 percent sensitivity and a 97.9 percent negative predictive value (NPV).
Senior Editor, Diagnostic Imaging

In a study of 351 women with BI-RADS 3-5 non-mass enhancement breast lesions, researchers found that multiparametric MRI offered 98.4 percent sensitivity and a 97.9 percent negative predictive value (NPV).
Recently published multinational research revealed that AZtrauma had a 95.6 percent AUC for detecting dislocations and a 97.5 percent AUC for detecting joint effusions.

Prostate AI reportedly enhances lesion detection, reduces segmentation variability between radiologists and improves workflow efficiencies in biopsy-recommended cases.

A retrospective comparison of AI platforms from seven different manufacturers for stand-alone lung cancer detection revealed sensitivity rates ranging between 20.8 percent to 77.8 percent.

The addition of density heterogeneity on CT to a predictive model for differentiating malignant and benign pulmonary nodules led to a greater than 15 percent improvement in the model’s AUC, according to a new multicenter study.

Delayed-only image acquisition for contrast-enhanced mammography after neoadjuvant chemotherapy offered a greater than 17 percent higher sensitivity rate than early-only image acquisition for detecting residual disease, according to a new study.

The ACIST Pro Diagnostic System, a variable-rate contrast management platform, reportedly offers real-time contrast tracking for image-guided interventional cardiology procedures and reduces set-up time by one-third in comparison to the ACIST CVI device.

Catch up on the top radiology content of the past week.

Researchers estimated that 17.9 million middle-aged women in the United States are overdue for breast, cervical or colorectal cancer screening, according to a new cross-sectional study.

In a new meta-analysis examining the impact of MRI-based AI models for predicting high-grade hepatocellular carcinoma, researchers noted a 10 percent decline in AUC between internal validation and external validation.

The updated Break Wave lithotripsy device for kidney stone treatment reportedly has ultrasound therapy probes with a 31 percent smaller footprint.

In a recent interview, Shadpour Demehri, MD, discussed new research findings suggesting a correlation between emphysema-like changes on CT and reduced bone mineral density in patients without chronic obstructive pulmonary disease (COPD).

In a study involving nearly 350 completed requests for CT scans at a pediatric hospital emergency department, researchers found that 54 percent were not appropriate according to American College of Radiology appropriateness criteria.

The combination of sustained high-gradient performance and AI capabilities with the Titanion MR may facilitate the use of imaging biomarkers that provide insight into tissue microstructure

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Four versions of the Artis vision platform and floor configurations of the Artis icono.explore and Artis genio systems feature the Optiq AI imaging chain, which reportedly facilitates real-time analysis and data optimization.

In a new capabilities analysis of 16 CE-marked AI software platforms for CT lung cancer screening, researchers found that only 6.7 percent of supporting peer-reviewed studies were prospective and that none of the studies assessed impact on patient outcomes.

In a recent interview with Diagnostic Imaging, Leslie Lamb, MD, MSc, discussed findings from new mammography research that showed an 89.3 percent sensitivity for detecting invasive lobular carcinoma (ILC) with adjunctive AI.

Catch up on the top radiology content of the past week.
Recent research demonstrated that non-physician operators with brief training on the Accuro XV ultrasound system had a greater than 90 percent rate for obtaining diagnostically adequate images.

In a recent interview with Diagnostic Imaging, Soroush Adam Ramin, MD, discussed the enhanced 3D visualization and prognostic capability of Unfold AI, an MRI-based software platform that was recently added to Medicare Physician Fee Schedules for the West Coast and Mountain West regions.

Increased paraspinal intermuscular adipose tissue (IMAT) on whole-body MRI was associated with a 67 percent higher likelihood of hypertension, according to new research involving over 11,300 participants without preexisting conditions.

Emerging MRI findings from phase 3 research revealed that over 28 percent of patients with perianal fistulizing Crohn’s disease achieved combined fistula remission 24 weeks after initiating treatment with the IL-23 inhibitor guselkumab.

In a recent interview with Diagnostic Imaging, Wendie Berg, MD, PhD, shared her perspective on various aspects of the controversial breast cancer screening guidance issued by the American College of Physicians (ACP), including the use of supplemental imaging in women with dense breasts.

While previous research has demonstrated the capability of the PET/CT agent (89Zr)girentuximab for detecting clear cell renal cell carcinoma (ccRCC), a new analysis reveals a 98 percent positive predictive value (PPV) for detecting non-ccRCC renal cancers.

Patients with PRECISE 4 or 5 scores based on prostate MRI had over a 4.5-fold higher likelihood of biopsy progression in comparison to those with PRECISE 1-3 scores, according to a new multicenter study involving over 1,600 patients.

Researchers found that deep learning assessment of mammograms had an 18 percent higher accuracy than breast density in predicting future breast cancer within five years, according to a new study involving over 67,000 women.

In a recent interview with Diagnostic Imaging, Manisha Bahl, MD, MPH, SBI, offers pertinent insights on the controversial breast cancer screening guidance recently issued by the American College of Physicians (ACP).

Catch up on the top radiology content of the past week.

In a recent interview, Stamatia Destounis, MD, offered her perspective about the recent American College of Physicians (ACP) guidance on breast cancer screening and concerns over recommendations in women with dense breasts and biennial versus annual mammography screening.